Home > Newsletters > Drug Industry Daily > Pfizer Settles FCPA Charges; Settlement Lessened by Company’s Compliance Steps
Drug Industry Daily
Aug. 8, 2012 | Vol. 11 No. 155
Pfizer Settles FCPA Charges; Settlement Lessened by Company’s Compliance Steps
Pfizer will pay $60 million to resolve Foreign Corrupt Practices Act charges, but its proactive corporate compliance program allowed it to avoid even harsher penalties — including imposition of an outside corporate monitor.
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.